This meeting will consider universal challenges of biological resistance to agents that are designed to improve human health and food production. A strong focus will be in the broad areas of drug resistance in infectious diseases – especially neglected diseases of the developing world – as well as drug resistance in cancer and in agricultural crop protection. Scientists working on antibacterials, antifungals, antiparasitics, antivirals, anticancer agents, as well as herbicides and insecticides used in the agricultural sector, will find the content relevant. Diverse participants from these orthogonal disciplines will be assembled; most of whom seldom interact directly for an extended period of time. The Conference setting will help break interdisciplinary barriers, help participants learn from one another, encourage uninhibited exploration, build long-lasting relationships and catalyze future transformative collaborations. Responses to seemingly unavoidable forces driving drug resistance require continual, creative scientific advances and tightly integrated discussions with global policy makers.
The success of this conference counts on a broad representation of disciplinary expertise, varying seniority, and wide geographic and cultural perspectives. As in previous years, we expect representation from academics, government organizations, and industry – small and large. Speakers and attendees with international reputation in drug resistance will bring experiences from many different countries and continents. In particular, the meeting leadership welcomes – and will seek out – timely and novel poster session presentations. These should benefit greatly from the GRC format. Fourteen outstanding poster presentations will be selected for short oral talks.
The topics and speakers for the conference sessions are displayed below (italics denote discussion leaders). The Conference Chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by February 12, 2016. Please check back for updates.
Keynote Session: Threats and Responses
(Jean Patel / Dennis Dixon / Rick Fairhurst)
Understanding Resistance
(Amy Anderson / Robert Douglas Sammons / Erica Ollmann Saphire / Ashley Vaughan)
Paths to Stable Resistance Traits
(Didier Leroy / Marc Ouellette / David Skurnik)
Avoiding Resistance
(Michael Cynamon / Martin Burke / Robert Bonomo)
Advancing Tools and Methods
(Celia Schiffer / Harren Jhoti / Sriram Subramaniam)
Exploiting Existing Resistance
(Juswinder Singh / Skirmantas Kriaucionis / Margaret Riley)
Targeting Host Processes
(Mariano Garcia-Blanco / Michael Starnbach / Alexis Kaushansky)
Generalizable Strategies? Combinations, Multi-Targeting, or Privileged Targets
(Pradipsinh Rathod / Timothy Wells / Ronald Farquhar / Gautan Dantas)
Keynote Session: Connecting Paths to Patients
(Jared Silverman / Keith Jerome / Wendy Sanhai)
06月12日
2016
06月17日
2016
终稿截稿日期
注册截止日期
留言